Completed NA INTERVENTIONAL 2-arm NCT01779635

Efficacy and Safety of Heparin-grafted Membrane for CRRT (CARROM)

Continuous Renal Replacement Therapy With Anticoagulation-free Regimen in Bleeding-risk Patients Using oXiris Membrane - CARROM Study

Sponsor: National University Hospital, Singapore

Conditions Acute Kidney Injury Coagulopathy Hemorrhage

Interventions M150 as first filter oXiris as first filter

Updated 6 times since 2017 Last updated: May 25, 2017 Started: Aug 31, 2013 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01779635, this NA trial focuses on Acute Kidney Injury and Coagulopathy and remains completed. Sponsored by National University Hospital, Singapore, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jul 2017 — Jun 2018 [monthly]

Completed NA

Status: Unknown Status → Completed

▶ Show 1 earlier version

Jan 2017 — Jul 2017 [monthly]

Unknown Status NA

First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National University Hospital, Singapore

Data source: National University Hospital, Singapore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Singapore, Singapore